SCHEMBL30983950

SCHEMBL30983950

Cc1c(-c2nc3c(OC4(C)CC4)ncnc3n2Cc2ccccc2)ccnc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 3/20 0.40
▸ DAPK1 P53355 2/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ NR2F2 P24468 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ HTR6 P50406 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983903 0.83 PIK3CD (0.42) PIK3CDDAPK1MAPK1HSD17B10ADORA2A
SCHEMBL30983901 0.82 PIK3CD (0.41) PIK3CDDAPK1MEN1KMT2ANR2F2
SCHEMBL30983572 0.81 HTR6 (0.40) PIK3CDHTR6
SCHEMBL30983805 0.80 PIK3CD (0.41) PIK3CDDAPK1MAPK1HSD17B10ADORA2A
SCHEMBL30983821 0.80 PIK3CD (0.40) PIK3CDDAPK1MEN1KMT2ANR2F2
SCHEMBL30984032 0.79 PIK3CD (0.41) PIK3CDDAPK1MEN1KMT2ANR2F2
SCHEMBL30983784 0.79 PIK3CD (0.40) PIK3CDDAPK1MEN1KMT2ANR2F2
SCHEMBL30983776 0.79 PIK3CD (0.40) PIK3CDDAPK1MEN1KMT2ANR2F2
SCHEMBL31269007 0.79 KMT2A (0.46) PIK3CDDAPK1MEN1KMT2AKDM4E
SCHEMBL30983826 0.78 PIK3CD (0.39) PIK3CDDAPK1MEN1KMT2ANR2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback